In Utero Cocaine Exposure: A Thorny Mix of Science and Mythology

Alex C. Vidaeff; Joan M. Mastrobattista

doi:10.1055/s-2003-40604

American Journal of Perinatology, Table of Contents

Am J Perinatol 2003; 20(4): 165-172
DOI: 10.1055/s-2003-40604

REVIEW ARTICLE

In Utero Cocaine Exposure: A Thorny Mix of Science and Mythology

Alex C. Vidaeff, Joan M. Mastrobattista

Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas, Houston Medical School, Houston, Texas

Abstract

ABSTRACT

Fetal cocaine exposure has proven to be an area of medicine that has generated more heat than light. Although many reports associate cocaine with a variety of isolated structural anomalies, there is no detectable syndromic clustering, raising doubts about a real causal association or a specific teratogenic action. Potential confounding variables, including the abuse of other drugs, pregnancy deprivations, and socially patterned maternal behaviors, have limited the reliability of observational studies, making it difficult to demonstrate effects solely attributable to cocaine. The clinical expression of in utero cocaine exposure is contextual, critically dependent on the biology/environment interplay. The present work summarizes the fetal structural anomalies that have been associated in the literature with cocaine use during pregnancy, and reviews the putative mechanisms of fetal impairment secondary to cocaine exposure. The final discussion of methodologic issues in cocaine epidemiology highlights the need for innovative approaches to assure that the myths conjured up about “crack babies” are replaced with reliable, high-quality scientific data.

KEYWORDS

Cocaine - fetus - pregnancy - fetal anomalies

Full Text

References

REFERENCES

1 Koren G, Gladstone D, Robeson C, Robieux J. The perception of teratogenic risk of cocaine. Teratology . 1992; 46 567-571
2 Buehler B A, Conover B, Andres R L. Teratogenic potential of cocaine. Semin Perinatol . 1996; 20 93-98
3 Koren G. Cocaine and the human fetus: the concept of teratophilia. Neurotoxicol Teratol . 1993; 15 301-304
4 Bellini C, Massocco D, Serra G. Prenatal cocaine exposure and the expanding spectrum of brain malformations [letter]. Arch Intern Med . 2000; 160 2393
5 Kain Z N, Mayes L C, Ferris C H, Pakes J, Schottenfeld R. Cocaine-abusing parturients undergoing cesarean section: a cohort study. Anesthesiology . 1996; 86 1028-1035
6 Gomez-Anson B, Ramsey R G. Pachygyria in a neonate with prenatal cocaine exposure: MR features. J Comput Assist Tomogr . 1994; 18 637-639
7 Good W V, Ferriero D M, Golabi M, Kobori J A. Abnormalities of the visual system in infants exposed to cocaine. Ophthalmology . 1992; 99 341-346
8 Dominguez R, Aguire Vila-Coro A, Slopis J M, Bohan T P. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child . 1991; 145 688-695
9 Bingol N, Fuchs M, Diaz V, Stone R K, Gromisch D S. Teratogenicity of cocaine in humans. J Pediatr . 1987; 110 93-96
10 Finnell R H, Toloyan S, van Waes M, Kauvas P W. Preliminary evidence for cocaine embryopathy in mice. Toxicol Appl Pharmacol . 1990; 103 228-237
11 Battin M, Albersheim S, Newman D. Congenital genitourinary tract abnormalities following cocaine exposure in utero. Am J Perinatol . 1995; 12 425-428
12 Behnke M, Eyler F D, Conlon M, Wobie K, Stewart N, Cumming W. Incidence and description of structural brain abnormalities in new-borns exposed to cocaine. J Pediatr . 1998; 132 291-294
13 Koebbe M J, Golden J A, Bennett G, Finnell R H, Mackler S A. Effects of prenatal cocaine exposure on embryonic expression of sonic hedgehog. Teratology . 1999; 59 12-19
14 Volpe J J. Effects of cocaine use on the fetus. New Engl J Med . 1992; 327 399-407
15 Stafford J R, Rosen T S, Zaider M, Merriam J C. Prenatal cocaine exposure and the development of the human eye. Ophthalmology . 1994; 101 301-308
16 Salamy A, Eldredge L. Risk for ABR abnormalities in the nursery. Electroencephalogr Clin Neurophysiol . 1994; 92 392-395
17 Salamy A, Eldredge L, Anderson J, Bull D. Brain-stem transmission time in infants exposed to cocaine in utero. J Pediatr . 1990; 4 627-629
18 Little B B, Wilson G N, Jackson G. Is there a cocaine syndrome?. <~>Dysmorphic and anthropometric assessment of infants exposed to cocaine. Teratology . 1996; 54 145-149
19 Frank D A, Augustyn M, Zuckerman B S. Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure. Ann N Y Acad Sci . 1998; 846 41-50
20 Heier L A, Carpanzano C R, Mast J, Brill P W, Winchester P, Deck M D. Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. Am J Neuroradiol . 1991; 12 951-956
21 Chasnoff I, Burns K, Burns W. Cocaine use in pregnancy: perinatal morbidity and mortality. Neurotoxicol Teratol . 1987; 9 291-293
22 Durand D J, Espinoza A M, Nickerson B G. Association between prenatal cocaine exposure and sudden infant death syndrome. J Pediatr . 1990; 117 909-911
23 Bauchner H, Zuckerman B, McClain M, Frank D, Fried L E, Kayne H. Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr . 1988; 113 831-834
24 Martin M L, Khoury M J, Cordero J F, Waters G D. Trends in rates of multiple vascular disruption defects, Atlanta 1968-1989; is there evidence of a cocaine teratogenic epidemic?. Teratology . 1992; 45 647-653
25 Lutiger B, Graham K, Einarson T R, Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology . 1991; 44 405-414
26 Addis A, Moretti M E, Syed F A, Einarson T R, Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol . 2001; 15 341-369
27 Behnke M, Eyler F D, Garvan C W, Wobie K. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics . 2001; 107 E74
28 Frank D A, Augustyn M, Knight W G, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure. JAMA . 2001; 285 1613-1625
29 Woods J R. Maternal and transplacental effects of cocaine. Ann N Y Acad Sci . 1998; 846 1-10
30 Woods J R, Plessinger M A, Clark K E. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA . 1987; 257 957-961
31 Sandberg J A, Olsen G D. Cocaine and metabolite concentrations in the fetal guinea pig after chronic maternal cocaine administration. J Pharmacol Exp Ther . 1992; 260 587-591
32 Dixon S D. Effects of transplacental exposure to cocaine and methamphetamine on the neonate. West J Med . 1989; 150 436-442
33 Hoyme H E, Lyons J K, Dixon S D. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics . 1990; 85 743-747
34 Levy M, Koren G. Obstetric and neonatal effects of drugs of abuse. Emerg Med Clin North Am . 1990; 8 633-653
35 Sallee F R, Katikaneni L P, McArthur P D, Ibrahim H M, Nesbitt L, Sethuraman G. Head growth in cocaine-exposed infants: relationship to neonate hair level. J Dev Behav Pediatr . 1995; 16 77-81
36 Substance Abuse and Mental Health Services Administration Office of Applied Studies. National Household Survey on Drug Abuse: Population Estimates 1999. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2001;DHHS Project 7190
37 Church M W, Overbeck G W. Prenatal cocaine exposure in the Long-Evans rat. Neurotoxicol Teratol . 1990; 12 327-334
38 Hume R F, Gingras J L, Martin L S, Hertzberg B S, O'Donnell K J, Killann A P. Ultrasound diagnosis of fetal anomalies associated with in utero cocaine exposure: further support for cocaine-induced vascular disruption teratogenesis. Fetal Diagn Ther . 1994; 9 239-245
39 Rieder M J. How much fire under the smoke?. <~>The effects of exposure to cocaine on the fetus. Can Med Assoc J . 1994; 151 1567-1569
40 Tronick E Z, Frank D A, Cabral H, Mirochnick M, Zuckerman B. Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics . 1996; 98 76-83
41 Neuspiel D R, Markowitz M, Drucker E. Intrauterine cocaine, lead, and nicotine exposure and fetal growth. Am J Public Health . 1994; 84 1492-1495
42 McCance E F, Price L H, Kosten T R, Jatlow P I. Cocaethylene: pharmacology, physiology, and behavioral effects in humans. J Pharmacol Exp Ther . 1995; 274 215-223
43 Singer L T, Salvator A, Arendt R, Minnes S, Farkas K, Kliegman R. Effects of cocaine/polydrug excposure and maternal psychological distress on infant birth outcomes. Neurotoxicol Teratol . 2002; 24 127-135
44 Lou H C, Hansen D, Nordentroft M. Prenatal stressors of human life affect fetal brain development. Dev Med Child Neurol . 1994; 36 826-832
45 Miller Jr M J, Boudreaux M C. A study of antenatal cocaine use: chaos in action. Am J Obstet Gynecol . 1999; 180 1427-1431
46 Greenland S, Robins J M, Pearl J. Confounding and collapsibility in casual inference. Stat Sci . 1999; 14 29-46
47 Maldonado G, Greenland S. Estimating causal effects. Int J Edpidemiol . 2002; 31 422-429
48 Greenland S, Pearl J, Robins J M. Causal diagrams for epidemiologic research. Epidemiol . 1999; 10 37-48